Stay up to date with the latest developments in artificial intelligence.
Flywheel announced an integration with AWS HealthImaging to streamline the management of medical imaging data for clinical trials, research, and AI development. The collaboration enables organizations to create standardized, analysis-ready imaging datasets across regulated and exploratory workflows.
The Industrial Technology Research Institute (ITRI) has opened the AI Robotics Innovation and Development Center in Tainan to advance AI robotics in healthcare, logistics, food services, and disaster response while supporting startups with testing and incubation resources.
NeuroDiscovery AI has introduced NeuroTerminal, a platform built for neurology research that integrates clinical trial management, real world data, and medical affairs to speed up patient recruitment and therapy access.
Biotia has introduced BIOTIA-DX Resistance, an antimicrobial resistance profiling tool now integrated into its CLEP-approved BIOTIA-ID Urine Test for clinical use across the U.S. The platform provides rapid resistance prediction to guide treatment for complicated urinary tract infections.
Blackbaud has released its 2025 Impact Report, outlining its progress in responsible AI governance, sustainability, and employee engagement. The report highlights the company's carbon neutrality achievement and expanded oversight through a new AI Council.
Open Medicine has launched a new platform called Living Algorithms, designed to help clinicians make faster and more informed cancer treatment decisions by sharing continuously updated, interactive treatment pathways authored by leading physicians.
Verkor has launched VerTQ, a silicon IP accelerator implementing Google's TurboQuant algorithm to reduce large language model memory usage by over four times while maintaining performance. The chip was autonomously designed by Verkor's Conductor 2.0 AI platform and targets edge AI applications.
MajorKey Technologies has been chosen by a U.S. Department of Defense agency to deliver NomadID, a disconnected identity and access management solution, to support secure operations in communication-degraded environments.
A new report from 5WPR shows that Novo Nordisk and Eli Lilly account for nearly all GLP-1 citations across AI platforms like ChatGPT, Claude, and Perplexity, with their brands controlling 57% of total mentions in the weight loss category.
FADEL has launched AIVA Intelligence, an AI assistant that provides real time contract analysis and performance insights within licensing and compliance workflows. The tool enables users to access contract and policy data through natural language queries, improving efficiency across legal and finance teams.
The Universities Space Research Association has created a new subsidiary, USRA Energy LLC, to advance the U.S. Department of Energy's initiatives in artificial intelligence, nuclear innovation, and workforce development.
Riverside Research and Plexus Corp. have announced a partnership to develop reusable modular hardware and software for intelligence and defense applications, beginning with the Aegis R52L Enhanced Retransmission Device.
Pulumi has introduced new capabilities for its Neo AI agent and announced partnerships with NVIDIA and CoreWeave to simplify AI infrastructure deployment and operations.
Automation Anywhere has launched EnterpriseClaw, a new platform created with Cisco, NVIDIA, Okta, and OpenAI to enable AI agents to operate securely across enterprise environments including cloud, desktop, and on-premises systems.
PA-AI has launched HIL, the Human Intelligence Layer, designed to integrate emotional, behavioral, and cultural intelligence into enterprise AI decision-making.
EBSCO Information Services has partnered with Perplexity to include EBSCOhost content in Perplexity’s Premium Sources, allowing users to access peer reviewed journals directly within the AI platform.
Sino Biological has launched the XPressMAX Cell Free Protein Synthesis Kit, enabling protein and antibody synthesis in three hours to support AI driven high throughput screening for antibody drug discovery.
28bio has launched CNS-3D Inflammatory Organoids, a human brain tissue model designed to test the efficacy of anti-inflammatory drugs in central nervous system diseases. The organoids combine neurons, astrocytes, and microglia to simulate inflammation and assess therapeutic responses.
Enigma Aerospace has signed a memorandum of understanding with Re:Build Manufacturing to develop and produce the Phoenix P-1000 autonomous logistics aircraft at scale, targeting flight testing within 12 months and high-rate production soon after.
Researchers from Southeast University and Korea University have created advanced copper catalysts that improve the efficiency and stability of converting carbon dioxide into valuable fuels, using both experimental design and machine learning models.
Daily report covering major AI developments and industry news, with both top stories and complete market updates
